Group FPGC (mg/dL) NORM 86.30 ± 0.15n DIAB 368.20 ± 0.72a HrACMO 133.00 ± 0.63b HrASGA 105.70 ± 0.71e,f,g,h HrEMCO 118.00 ± 0.92c,d HrHIRO 112.50 ± 0.70d,e HrAGAM 66.30 ± 0.71q HrAGEC 81.00 ± 0.39n,o,p HrAGHR 112.50 ± 0.42d,e,f HrAMEC 97.20 ± 0.51l,m HrAMHR 105.00 ± 0.62e,f,g,h,i HrECHR 103.50 ± 0.79f,g,h,i,j HrAGEH 103.00 ± 0.81f,g,h,i,j,k HrAMAE 84.70 ± 0.51n,o HrAMAH 124.30 ± 0.92c HrAMEH 112.00 ± 0.71d,e,f,g HrAAEH 97.30 ± 0.85l

The mean (X) ± S.D of six (n = 6) determinations. Means in the column with the same letter are not significantly different at p>0.05 according to LSD. FPGC>110 mg/dL = hyperglycemia.

Table 1: Fasting plasma glucose concentrations of normal, diabetic and treated rats.